MISSION Therapeutics Funding: $114M Raised, Series A (2025)
MISSION Therapeutics is based in Cambridge, UK. It has raised $114M in total funding. Latest round: Series A.
MISSION Therapeutics funding overview
MISSION Therapeutics is based in Cambridge, UK. MISSION Therapeutics has raised $114M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series A announced in October 2025. The round record for MISSION Therapeutics runs through 2025; nothing later has been disclosed. Investors on record include Pfizer Venture Investments, Sofinnova Partners, Imperial Innovations, SR One, Roche Venture Fund. 5 distinct backers are named across the disclosed rounds.
MISSION Therapeutics at a glance
Total raised
$114M
Latest round
Series A
Latest round date
October 2025
Headquarters
Cambridge, UK
Notable investors
Pfizer Venture Investments, Sofinnova Partners, Imperial Innovations, SR One, Roche Venture Fund
Frequently asked about MISSION Therapeutics funding
How much has MISSION Therapeutics raised?
MISSION Therapeutics has raised $114M in total disclosed funding across the rounds on record.
Who has invested in MISSION Therapeutics?
Pfizer Venture Investments, Sofinnova Partners, Imperial Innovations, SR One, Roche Venture Fund are named among the investors backing MISSION Therapeutics.
What was the latest MISSION Therapeutics funding round?
The most recent disclosed round is a Series A, announced in October 2025.
Where is MISSION Therapeutics based?
MISSION Therapeutics is based in Cambridge, UK.
When did MISSION Therapeutics last raise?
The last disclosed MISSION Therapeutics round closed in October 2025 at Series A.
Every MISSION Therapeutics figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare companies in Cambridge at a similar stage.
